AOPEP and cancer: The secondary objective is to determine the relationship between clinical (age at diagnosis, diagnosis, overweight or obesity status) and therapeutic parameters (exposure to doxorubicin, methotrexate and corticosteroids) and the lipid and Apo profile of HDL fractions in post-treatment pediatric cancer patients.